Erwin M. Schoof

Associate Professor, DTU Bioengineering (Section for Medical Biotechnology)

Email: erws@dtu.dk

Erwin M. Schoof is a group leader at the Department of Biotechnology and Biomedicine (DTU Bioengineering) and coordinating professor in the Technical University Hospital (TUH) collaboration between DTU and The Capital Region of Denmark (Region H). He leads the Cell Diversity Lab (CDL), whose overall research goal is to combine experimental and computational methods to understand how cellular heterogeneity contributes to disease phenotypes and how it can be therapeutically exploited. The group develops advanced single-cell and spatial proteomics technologies, with main focus areas including cancer stem cells, hematopoiesis, solid tumors, and cell heterogeneity in general. Within TUH, his ambition is to build cross-disciplinary platforms that integrate mass spectrometry–based proteomics with other ‘omics modalities and data-driven modelling in clinical research and digital pathology, enabling more precise patient stratification, biomarker discovery, and improved treatment strategies in cancers and other malignancies. 

 

DTU Bioengineering

The Department of Biotechnology and Biomedicine (DTU Bioengineering) is an international leader in biotechnology and biomedicine committed to engineering the molecules of life for a sustainable and healthy future. With an engineering-driven approach, the department brings unique expertise to the growing bio-based economy and the transformation of health systems toward personalized medicine.  DTU Bioengineering's mission is to advance knowledge and technology for understanding biological and molecular systems, contributing to sustainable bioprocesses and improved human and planetary health.
The department addresses societal and scientific challenges through research, education, and innovation in microbiology, biomedicine, nanotechnology, and biotechnology. Key research sections include Medical Biotechnology, Microbial and Chemical Ecology, Synthetic Biology, and Protein Chemistry and Enzyme Technology.
Secondary Metabolites (CeMiSt), further driving innovation and supporting the UN Sustainable Development Goals. Research at DTU Bioengineering is supported by seven highly specialized research infrastructure facilities and a research data hub.